SPC477
Etrasimod eða lyfjafræðilega viðunandi salt þar af, á borð við etrasimodarginín
Status:
VeittApplication date:
17.7.2024Application published:
15.8.2024Grant published:
15.12.2025
Max expiry date:
21.7.2034Medicine name:
VelsipityMedicine for children:
No
Timeline
Today
17.7.2024Application
15.8.2024Publication
15.12.2025Registration
21.7.2034Expires
Marketing license
IS authorization number:
EU/1/23/1790Date:
13.3.2024
Foreign authorization number:
EU/1/23/1790Date:
16.2.2024
Owner
Name:
Arena Pharmaceuticals, Inc.Address:
66 Hudson Boulevard East, New York, NY 10001-2192 US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113 Reykjavík
Patent
Number:
EP2326621
Deadlines
TypeDeadline until
Type: Frestur til að fara yfir drög að vottorði
Deadline until: 22.11.2025